| http://dbpedia.org/ontology/abstract
|
Avax Technologies, Inc is a Philadelphia-b … Avax Technologies, Inc is a Philadelphia-based biotechnology company whose most advanced product candidate is MVax for melanoma. MVax is a cancer vaccine that received a Special Protocol Assessment agreement with the FDA in October 2006, and subsequently began a Phase III registration clinical trial in November 2007. In previous studies, MVax demonstrated a 5-year overall survival rate (OS)of 44% and response rate of 35% (13% CR, 22% PR).and response rate of 35% (13% CR, 22% PR).
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biomedicine +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Chairman +
|
| http://dbpedia.org/ontology/service
|
http://dbpedia.org/resource/Cancer_vaccines +
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Avax_Logo.png?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.avax-tech.com/ +
, http://www.genopoietic.fr/en/index.htm +
, http://www.facebook.com/group.php%3Fv=app_2373072738&ref=mf&gid=254690660179 +
|
| http://dbpedia.org/ontology/wikiPageID
|
25516263
|
| http://dbpedia.org/ontology/wikiPageLength
|
6014
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1106783632
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Philadelphia%2C_Pennsylvania +
, http://dbpedia.org/resource/Category:Companies_based_in_Philadelphia +
, http://dbpedia.org/resource/Ovarian_cancer +
, http://dbpedia.org/resource/Financial_crisis_of_2007%E2%80%932010 +
, http://dbpedia.org/resource/Food_and_Drug_Administration +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_Pennsylvania +
, http://dbpedia.org/resource/Lyon +
, http://dbpedia.org/resource/Biomedicine +
, http://dbpedia.org/resource/2%2C4-Dinitrophenol +
, http://dbpedia.org/resource/NSCLC +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Melanoma +
, http://dbpedia.org/resource/Category:Companies_traded_over-the-counter_in_the_United_States +
, http://dbpedia.org/resource/Category:Companies_with_year_of_establishment_missing +
, http://dbpedia.org/resource/Hapten +
, http://dbpedia.org/resource/Dendreon +
, http://dbpedia.org/resource/Cancer_vaccines +
, http://dbpedia.org/resource/Five-year_survival_rate +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Philadelphia +
, http://dbpedia.org/resource/Cancer_vaccine +
, http://dbpedia.org/resource/Response_rate_%28medicine%29 +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/homepage
|
http://www.genopoietic.fr/en/index.htm +
, http://www.avax-tech.com/ +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biomedicine +
|
| http://dbpedia.org/property/keyPeople
|
Richard Rainey
|
| http://dbpedia.org/property/locationCity
|
http://dbpedia.org/resource/Philadelphia%2C_Pennsylvania +
|
| http://dbpedia.org/property/locationCountry
|
http://dbpedia.org/resource/United_States +
|
| http://dbpedia.org/property/logo
|
Avax Logo.PNG
|
| http://dbpedia.org/property/name
|
Avax Technologies
|
| http://dbpedia.org/property/products
|
AC Vaccine
|
| http://dbpedia.org/property/services
|
http://dbpedia.org/resource/Cancer_vaccines +
|
| http://dbpedia.org/property/subsid
|
Genopoietic SA
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Template:Citation_needed +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Verification +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:OTCPink +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Companies_based_in_Philadelphia +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_traded_over-the-counter_in_the_United_States +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_Pennsylvania +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_with_year_of_establishment_missing +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Philadelphia +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Avax_Technologies?oldid=1106783632&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Avax_Logo.png +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.avax-tech.com/ +
, http://www.genopoietic.fr/en/index.htm +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Avax_Technologies +
|
| http://xmlns.com/foaf/0.1/name
|
Avax Technologies
|
| owl:sameAs |
https://global.dbpedia.org/id/4Tpt2 +
, http://yago-knowledge.org/resource/Avax_Technologies +
, http://dbpedia.org/resource/Avax_Technologies +
, http://www.wikidata.org/entity/Q4827853 +
, http://rdf.freebase.com/ns/m.09rx4mr +
|
| rdf:type |
http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/WikicatCompaniesListedOnThePinkSheets +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInPennsylvania +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://schema.org/Organization +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
|
| rdfs:comment |
Avax Technologies, Inc is a Philadelphia-b … Avax Technologies, Inc is a Philadelphia-based biotechnology company whose most advanced product candidate is MVax for melanoma. MVax is a cancer vaccine that received a Special Protocol Assessment agreement with the FDA in October 2006, and subsequently began a Phase III registration clinical trial in November 2007. In previous studies, MVax demonstrated a 5-year overall survival rate (OS)of 44% and response rate of 35% (13% CR, 22% PR).and response rate of 35% (13% CR, 22% PR).
|
| rdfs:label |
Avax Technologies
|
